US SB3311 | 2023-2024 | 118th Congress
Status
Spectrum: Slight Partisan Bill (Democrat 2-1)
Status: Introduced on November 15 2023 - 25% progression
Action: 2024-07-25 - Committee on Banking, Housing, and Urban Affairs. Hearings held.
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on November 15 2023 - 25% progression
Action: 2024-07-25 - Committee on Banking, Housing, and Urban Affairs. Hearings held.
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to direct the Secretary of Health and Human Services to conduct a demonstration program to test providing preferential treatment under the Medicare, Medicaid, and CHIP programs for certain drugs and biologicals manufactured in the United States.
Title
American Made Pharmaceuticals Act of 2023
Sponsors
| Sen. Tina Smith [D-MN] | Sen. Tom Cotton [R-AR] | Sen. Michael Bennet [D-CO] |
History
| Date | Chamber | Action |
|---|---|---|
| 2024-07-25 | Senate | Committee on Banking, Housing, and Urban Affairs. Hearings held. |
| 2023-11-15 | Senate | Read twice and referred to the Committee on Finance. |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/senate-bill/3311/all-info |
| Text | https://www.congress.gov/118/bills/s3311/BILLS-118s3311is.pdf |
